"Subsidiaries deliver strong revenue performance as MDCE advances development of innovative AI-driven health and nutrition technologies." MESA, ARIZONA / ACCESS…
This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in…
This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in…
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq…
CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company…
Winter Park, Florida--(Newsfile Corp. - November 24, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent…
First-of-its-kind AI-powered chronic care management platform moves clinically proven tools outside the doctor's office ARLINGTON, VA / ACCESS Newswire /…
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Vision Healthcare ("Vision"), a fast-growing European consumer healthcare platform, recently completed acquisitions of…
Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the…
Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the…